SCHEMBL6973851

SCHEMBL6973851

O=C1COc2ccccc2N1CCN1CCN(c2nccc3ccccc23)CC1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.59
HTR2A P28223 5/20 0.59
MCHR1 Q99705 4/20 0.59
HTR1A P08908 2/20 0.55
HTR1D P28221 1/20 0.55
HTR1B P28222 1/20 0.55
SLC6A4 P31645 1/20 0.55
DRD4 P21917 1/20 0.54
HRH4 Q9H3N8 1/20 0.49
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
DRD3 P35462 1/20 0.47
POLB P06746 1/20 0.46
MAPK1 P28482 1/20 0.46
KCNH2 Q12809 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6711485 0.98 DRD2 (0.57) DRD2HTR2AMCHR1HTR1AHTR1D
SCHEMBL7082418 0.94 DRD2 (0.65) DRD2HTR2AMCHR1HTR1AHTR1D
SCHEMBL6714648 0.90 HTR1A (0.49) DRD2HTR2AMCHR1HTR1AHTR1D
SCHEMBL7087322 0.87 HRH4 (0.51) DRD2HTR2AMCHR1HTR1AHTR1D
SCHEMBL6715832 0.84 HTR1A (0.63) DRD2HTR1AHTR1DHTR1BSLC6A4
SCHEMBL6715989 0.83 DRD2 (0.59) DRD2HTR1ADRD4HRH4DRD3
SCHEMBL6711688 0.82 HRH4 (0.52) DRD2HTR1AHTR1DHTR1BSLC6A4
SCHEMBL14761628 0.82 DRD4 (0.61) DRD2HTR2AMCHR1HTR1ADRD4
SCHEMBL7084667 0.81 HRH4 (0.51) DRD2HTR1AHTR1DHTR1BSLC6A4
SCHEMBL6715841 0.80 HRH4 (0.49) HTR1AHTR1DHTR1BSLC6A4HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296954-A1 BICYCLIC LACTAMS AND SULFONAMIDES WITH 5-HT1A-AFFINITY AND USE THEREOF FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA Abbott GmbH & Co. KG (DE) 2003-04-02 EP disclosed
WO-2002002529-A1 BICYCLIC LACTAMS AND SULFONAMIDES WITH 5-HT1A-AFFINITY AND USE THEREOF FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA ABBOTT GMBH & CO. KG (DE) 2002-01-10 WO disclosed